Expectant management with selective delayed intervention for favorable-risk prostate cancer

被引：0
|
作者：
Klotz, L [1 ]
机构：
[1] Univ Toronto, Sunnybrook & Womens Coll, Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada
来源：
PROSTATE AND RENAL CANCER, BENIGN PROSTATIC HYPERPLASIA, ERECTILE DYSFUNCTION AND BASIC RESEARCH: AND UPDATE | 2003年
关键词：
D O I：
暂无
中图分类号：
R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
摘要：
引用
收藏
页码：274 / 279
页数：6
相关论文
共 50 条
  • [31] Expectant management of localized prostate cancer
    Khan, MA
    Partin, AW
    Carter, HB
    UROLOGY, 2003, 62 (05) : 793 - 799
  • [32] Socioeconomic determinants are associated with the utilization and outcomes of active surveillance or watchful waiting in favorable-risk prostate cancer
    Huang, Da
    Ruan, Xiaohao
    Huang, Jingyi
    Zhang, Ning
    Jiang, Guangliang
    Gao, Yi
    Xu, Danfeng
    Na, Rong
    CANCER MEDICINE, 2023, 12 (08): : 9868 - 9878
  • [33] Multi-scale tissue architecture analysis of favorable-risk prostate cancer: Correlation with biochemical recurrence
    Pukl, Miha
    Keyes, Sarah
    Keyes, Mira
    Guillaud, Martial
    Volavsek, Metka
    INVESTIGATIVE AND CLINICAL UROLOGY, 2020, 61 (05) : 482 - 490
  • [34] The impact of genomic biomarkers on a clinical risk prediction model for upgrading/upstaging among men with favorable-risk prostate cancer
    Braun, Avery E.
    Chan, June M.
    Neuhaus, John
    Cowan, Janet E.
    Kenfield, Stacey A.
    Van Blarigan, Erin L.
    Tenggara, Imelda
    Broering, Jeanette M.
    Simko, Jeffry P.
    Carroll, Peter R.
    Cooperberg, Matthew R.
    CANCER, 2024, 130 (10) : 1766 - 1772
  • [35] Active surveillance with selective delayed intervention is the way to manage 'good-risk' prostate cancer
    Laurence Klotz
    Nature Clinical Practice Urology, 2005, 2 : 136 - 142
  • [36] Active surveillance with selective delayed intervention is the way to manage 'good-risk' prostate cancer
    Klotz, L
    NATURE CLINICAL PRACTICE UROLOGY, 2005, 2 (03): : 136 - 142
  • [37] Variability in prostate volume as determined by MRI versus ultrasound and its impact on treatment recommendations for patients with favorable-risk prostate cancer
    Murciano-Goroff, Yonina R.
    Wolfsberger, Luciant D.
    Parekh, Arti
    Fennessy, Fiona M.
    Tuncali, Kemal
    Orio, Peter F.
    Niedermayr, Thomas
    Suh, W. Warren
    Devlin, Phillip M.
    Tempany, Clare M.
    Paul Linh Nguyen
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [38] CAUSES OF DEATH IN MEN WITH PREVALENT DIABETES AND NEWLY DIAGNOSED HIGH- VERSUS FAVORABLE-RISK PROSTATE CANCER
    D'Amico, Anthony V.
    Braccioforte, Michelle H.
    Moran, Brian J.
    Chen, Ming-Hui
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 77 (05): : 1329 - 1337
  • [39] Lifetime Health and Economic Outcomes of Active Surveillance, Radical Prostatectomy, and Radiotherapy for Favorable-Risk Localized Prostate Cancer
    Degeling, Koen
    Corcoran, Niall M.
    Pereira-Salgado, Amanda
    Hamid, Anis A.
    Siva, Shankar
    IJzerman, Maarten J.
    VALUE IN HEALTH, 2021, 24 (12) : 1737 - 1745
  • [40] Pathologic Outcomes in Favorable-risk Prostate Cancer: Comparative Analysis of Men Electing Active Surveillance and Immediate Surgery
    Tosoian, Jeffrey J.
    Sundi, Debasish
    Trock, Bruce J.
    Landis, Patricia
    Epstein, Jonathan I.
    Schaeffer, Edward M.
    Carter, H. Ballentine
    Mamawala, Mufaddal
    EUROPEAN UROLOGY, 2016, 69 (04) : 576 - 581
12345